Announcements Trials
Browse Landscape

Phase

Phase NA 58Phase 2 36Phase 3 19Phase 1 18Phase 4 11Phase 1/2 6Phase EARLY_PHASE1 3Phase 2/3 2

Status

Completed 9Recruiting 5Unknown 2Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 33Carcinoma, Hepatocellular 27Neoplasms 19Colorectal Neoplasms 18Carcinoma, Non-Small-Cell Lung 16Stomach Neoplasms 15Leukemia, Myeloid, Acute 15Prostatic Neoplasms 12Lung Neoplasms 12Colonic Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Rectal Neoplasms 10Neoplasm Metastasis 8Leukemia 8Pancreatic Neoplasms 7NSCLC 6Multiple Myeloma 6Liver Neoplasms 6Esophageal Neoplasms 6Glioblastoma 5Small Cell Lung Carcinoma 4Recurrence 4Nasopharyngeal Carcinoma 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Head and Neck Neoplasms 4Gestational Trophoblastic Disease 4Esophageal Squamous Cell Carcinoma 4Cholangiocarcinoma 4Brain Neoplasms 4

Interventions

Lapatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × Urinary Bladder Neoplasms × Clear all
NCT03427034 2018-02-09

ABSEIL

Cambridge University Hospitals NHS Foundation Trust

Phase 2/3 Unknown
2,100 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria, Recurrence

NCT00949455 2015-04-15

LaMB

Queen Mary University of London

Phase 2/3 Unknown
204 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡